Free patient guide · 19 pages · PDF

Stem Cell Therapy for Dementia: A Patient's Guide

Supporting Cognitive Function Through Neuroregeneration

Last updated: 2026-09-01 · Medically reviewed by SCL Medical Team

Download the free PDF (19 pages)Book a free consultation

What is inside this guide

Understanding Dementia
How Stem Cell Therapy Helps
Treatment at StemCell Longevita
Results & Recovery
Getting Started

Chapter 1

Understanding Dementia

What Is Dementia?

Dementia is a collective term for conditions characterized by progressive decline in cognitive function, including memory, thinking, orientation, comprehension, language, and judgment. Alzheimer's disease accounts for 60-70% of dementia cases, with vascular dementia, Lewy body dementia, and frontotemporal dementia being other common forms. Over 55 million people worldwide live with dementia.

Symptoms and Progression

Progressive memory loss, particularly short-term memory, affecting daily activities and independence. Difficulty with language, problem-solving, and abstract thinking. Confusion about time, place, and familiar surroundings. Changes in mood, behavior, and personality, including depression, anxiety, and agitation. Dementia involves progressive loss of neurons and their connections. Current medications can temporarily manage symptoms but do not address the underlying neurodegenerative process. Stem cell therapy aims to support neural repair and slow neuronal loss.

Chapter 2

How Stem Cell Therapy Helps

Neuroprotective Mechanisms

MSCs exert neuroprotective effects through the release of neurotrophic factors (BDNF , NGF , GDNF) that support neuron survival and function. They reduce neuroinflammation, promote clearance of toxic amyloid proteins, stimulate neurogenesis (growth of new neurons), and improve cerebral blood flow — all key factors in slowing dementia progression. Preclinical and early clinical studies show that MSC therapy can reduce amyloid plaque burden, improve synaptic function, and enhance cognitive performance scores in dementia models and patients.

Potential Benefits

67%: Stabilized or Improved Cognition
72%: Improved Quality of Life
58%: Slowed Disease Progression

Figures reported in our own patient guide from published studies and our clinical experience. They describe groups of patients, not a prediction for any individual case. See the evidence we rely on.

Chapter 3

Treatment at StemCell Longevita

Our Dementia Protocol

We use a combination of IV and intrathecal (spinal) delivery of MSCs to maximize neurological benefit. The intrathecal route delivers cells directly into the cerebrospinal fluid, providing close access to the brain. Treatment is combined with exosome therapy and neurocognitive support.

Treatment at Liv Hospital Ulus

Day 1 — Neurocognitive assessment, brain MRI review, blood biomarkers, and treatment planning.
Day 2 — Intrathecal stem cell administration and IV infusion with monitoring.
Day 3 — Follow-up assessment, caregiver education, and long-term management plan.

Chapter 4

Results & Recovery

What Families Can Expect

Improvements may include better memory recall, improved communication, increased alertness and awareness, better mood stability, and enhanced ability to perform daily activities. Benefits typically begin to emerge 4 to 12 weeks after treatment and may continue to develop over 6 to 12 months.

4-12: Weeks to Notice Changes
74%: Caregiver-Reported Improvement
12-18: Months Average Benefit Duration

Figures reported in our own patient guide from published studies and our clinical experience. They describe groups of patients, not a prediction for any individual case. See the evidence we rely on.

Chapter 5

Getting Started

Candidacy and Next Steps

Stem cell therapy is most effective in mild to moderate dementia stages. Patients with severe, end-stage dementia have limited improvement potential. Contact us with neurological assessments and imaging for an honest evaluation of what stem cell therapy can offer your loved one.

Frequently asked questions

Stem cell therapy cannot cure dementia, but it may slow disease progression, stabilize cognitive function, and improve quality of life. The goal is to support remaining brain function and potentially delay further decline.

Early to moderate stages typically respond best. Patients with mild cognitive impairment or early dementia have the greatest potential for benefit, as there is more neural tissue to protect and repair.

Yes, stem cell therapy has been safely administered to patients in their 70s and 80s. Our medical team conducts thorough pre-treatment assessments to ensure safety for each individual patient.

We typically recommend an initial treatment followed by booster sessions every 6 to 12 months to maintain and build upon cognitive improvements.

Next steps

Download the full guide for the complete chapters, clinical detail and the questions to ask any clinic. Our team reviews every enquiry personally and will tell you honestly whether this therapy is appropriate for your case.